Hematology Oncology Care Team

Medical Oncology

Hematologist Oncologist

Peter M. Barth, MD, is a hematologist/oncologist at Lifespan Cancer Institute who specializes in the treatment of benign and malignant blood disorders. He completed his residency at Temple University Hospital in Philadelphia and his fellowship at Rhode Island Hospital with Brown University. He has presented his work on platelet disorders and blood count abnormalities on a national level. His research interests are in the treatment of plasma cell neoplasms such as multiple myeloma. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the International Myeloma Society and the American Medical Association.

Hematologist Oncologist

James N. Butera, MD, is a board-certified hematologist/oncologist who treats patients with blood disorders including bleeding and clotting problems, leukemia, lymphoma, and multiple myeloma. He sees patients at the Lifespan Cancer Institute at Rhode Island Hospital and the Lifespan Ambulatory Care Center in East Greenwich. He is a clinical associate professor of medicine at The Warren Alpert Medical School of Brown University.

Dr. Butera’s research findings have been published in numerous peer-reviewed journals, and he is the site principal investigator at Lifespan for several chemotherapy studies. Among other honors, Dr. Butera has received the Brown University Dean’s Excellence in Teaching Award multiple times and been named one of Rhode Island Monthly magazine’s Top Docs for several years.

Hematologist/Oncologist

Pamela C. Egan, MD, is a hematologist at Rhode Island Hospital. Her interests include the treatment of acute leukemia, palliative care in hematologic malignancies, and physician advocacy education. She earned her medical degree from SUNY Upstate School of Medicine in Syracuse, New York, and completed her residency and fellowship at Rhode Island Hospital and The Warren Alpert Medical School of Brown University. Dr. Egan is a member of the American Society of Hematology and The American College of Physicians.

Hematologist/Oncologist

Thomas A. Ollila, MD, is an hematologist/oncologist at Lifespan Cancer Institute. He earned his medical degree from Drexel University College of Medicine, and completed his residency in internal medicine and fellowship in hematology/oncology at Rhode Island Hospital. Dr. Ollila´s research interests include translational and clinical outcomes in lymphoma as well as addressing opioid use in cancer patients and survivors. In 2018, he was given the Conquer Cancer Foundation Merit Award by the American Society of Clinical Oncology. He is a member of the Alpha Omega Alpha Medical Honors Society, the American Society of Hematology and the American Society of Clinical Oncology.

Hematologist/Oncologist

Adam Olszewski, MD is a board-certified clinical hematologist/oncologist and researcher with the Lifespan Cancer Institute at Rhode Island Hospital. Dr. Olszewski is also an assistant professor of clinical medicine at The Warren Alpert Medical School of Brown University. He previously served as a cancer committee chair member and clinical oncologist/hematologist at the Cancer Center at Memorial Hospital of Rhode Island. Dr. Olszewski was also a physician director of outpatient infusion services at Kent County Hospital. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Hematologist Oncologist
Adult Hematologist Oncologist
Hematologist/Oncologist
Associate Physician-in-Chief, The Miriam Hospital; Medical Director, Lifespan Cancer Institute
Hematologist/Oncologist

Robert Sokolic, MD, FACP, is a hematologist and oncologist at Lifespan Cancer Institute. He is a member of the sickle cell disease multidisciplinary team and specializes in primary disorders of bone marrow. His research interests include sickle cell disease and primary immunodeficiency diseases. His work has been published in many scientific journals and book chapters, including the New England Journal of Medicine. He is a member of the American Society of Hematology, Clinical Immunology Society, the American Society of Cell and Gene Therapy and the American Society for Blood and Marrow Transplantation.

Radiation Oncology

Oncologist-in-Chief, Radiation Oncology

David Wazer, MD, is director of the Lifespan Cancer Institute of Rhode Island, The Miriam and Newport hospitals as well as radiation oncologist-in-chief at Rhode Island Hospital. He is professor and chairman of the departments of radiation oncology at both The Warren Alpert Medical School of Brown University and Tufts University School of Medicine.

Dr. Wazer is an internationally recognized expert in the application of new technology in the field of radiation oncology. He has published more than 200 scientific articles, written several books, and is also editor-in-chief of the American Journal of Clinical Oncology. Wazer earned his medical degree (with honors) from the New York University School of Medicine, New York, NY, and also completed a research fellowship in neurochemistry at New York University. Dr. Wazer obtained his clinical training in internal medicine at Brown University and in radiation oncology at Tufts University. His clinical research interests include the study of the efficacy, toxicity, and cost/utility analysis of image-guided radiation therapy, partial breast irradiation, electronic brachytherapy and hyperthermia. He is actively involved in the development of clinical trials for cancers of the breast, skin, gastrointestinal tract and lung.

Dr. Wazer is a fellow of the American Society for Radiation Oncology and the American College of Radiation Oncology and a member of the Radiation Research Society, American Society of Clinical Oncology, the American College of Radiology, the American Radium Society, the American Association for the Advancement of Science and the American Brachytherapy Society.

Radiation Oncologist

Timothy J. Kinsella, MD, is an internationally recognized radiation oncologist and a research scholar professor of radiation oncology at The Warren Alpert Medical School of Brown University. Kinsella received his undergraduate degree from St. John Fisher College in Rochester, NY; a master’s degree with honors from Brown University; and both his master of science in radiation biology and his medical degree from the University of Rochester School of Medicine in Rochester, NY. He completed his residency training in internal medicine at the Mayo Clinic, fellowship training in medical oncology at Dana Farber Cancer Institute in Boston, MA, and his residency training in radiation oncology at the Harvard Radiation Oncology Program. He was a fellow of the American Society of Therapeutic Radiology and Oncology. Kinsella has been editor-in-chief of Frontiers in Radiation Oncology and editorial board member of eight other journals. He is board certified in internal medicine, medical oncology and radiation oncology. His areas of clinical expertise include the treatment of bone and soft tissue sarcomas, brain tumors, lymphomas, gastrointestinal cancers and pediatric cancers. He has laboratory expertise in the development of intraoperative radiotherapy, radiation sensitizing drugs and small molecules that modify DNA repair processing of radiation damage.

Radiation Oncologist

Kara Leonard, MD, is a radiation oncologist at Rhode Island Hospital and an assistant professor of radiation oncology at The Warren Alpert Medical School of Brown University. Leonard received her undergraduate degree in neuroscience from Columbia University in New York, her master of science from Villanova University in Villanova, Pennsylvania, and her medical degree from Albany Medical College in Albany, New York. She completed an internship in internal medicine at Albany Medical Center, followed by a residency in radiation oncology at Tufts Medical Center in Boston. She specializes in treating breast, gastrointestinal, and head and neck cancers. She is a member of several national honor societies, including Alpha Omega Alpha and Psi Chi.

Patient Navigators

Bethany Cunningham, RN, OCN
Patient Navigator

Bethany Cunningham, RN, OCN, is a certified oncology nurse and a patient navigator. She is a graduate of the Community College of Rhode Island in Lincoln, RI, and Purdue University Global. She works closely with the Lifespan Cancer Institute hematology team. Her role involves assisting hematology/oncology physicians, as well as helping patients and their families navigate the continuum of cancer care. She serves as co-chair of the Patient and Family Advisory Council at The Miriam Hospital.

Margot Murphy, RN
Patient Navigator

Margot Murphy, RN, is a certified patient navigator and a graduate of Concord Hospital School of Nursing in Concord, NH. She works closely with the Lifespan Cancer Institute breast cancer team, hematology team, and Fellows Clinic. Her role involves assisting patients and their families to guide them through the medical process and provide comfort and knowledge.